| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.26 | 3e-07 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.17 | 6e-07 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.17 | 8e-07 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-06 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-06 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-06 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.14 | 6e-06 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | 0.13 | 4e-05 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.14 | 5e-05 |